Clinical trials
Urinary Tract Infections (UTIs) clinical trials
Below are recruiting urinary tract infections (utis) clinical trials, each written for real people, not researchers. We’re tracking 58 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07233837Recruiting
Cleaning ICU surfaces with hydrogen peroxide and UV light
This trial tests a new way to clean surfaces in intensive care units (ICUs) using hydrogen peroxide and ultraviolet (UV) light. It aims to see if this method reduces infections in patients.
Barbalha, CearáAges 18 years+ - NCT06918769Recruiting
Using a new urine test to reduce unnecessary antibiotics for bladder infections
This study tests a new urine test (the UF-5000) to see if it can help doctors decide who really needs antibiotics for a bladder infection. The goal is to avoid giving antibiotics when they are not needed.
Hong Kong, Hong KongAges 18–99 - NCT07202949RecruitingPhase 2
Extended antibiotics with methenamine for chronic urinary tract infection
This trial compares a longer, higher-dose antibiotic course combined with methenamine hippurate (a urinary antiseptic) against standard care (low-dose antibiotics or methenamine alone) for women with chronic urinary tract infections. It aims to see if the extended treatment is more effective at relieving persistent symptoms.
LondonAges 18 years+ - NCT06962644Recruiting
UTI and Preeclampsia in Pregnancy
This study looks at whether a urinary tract infection (UTI) during pregnancy is linked to preeclampsia (a serious condition involving high blood pressure). It may help pregnant women who have a UTI and want to understand their risk.
IslamabadAges 18–35 - NCT07093749Recruiting
Antibiotics and symptom tracking in children
This study looks at how children with common infections feel while taking antibiotics. The goal is to better understand symptom patterns during treatment.
Melbourne, VictoriaAges 4–17 - NCT06976125Recruiting
Using a model to guide antibiotic choice for UTI after ER visit
This trial tests whether a prediction model can help doctors choose the right antibiotic for women with a urinary tract infection (UTI) after an emergency room visit. It aims to improve treatment and reduce unnecessary antibiotics.
Cleveland, OhioAges 18 years+ - NCT06940622Recruiting
D-mannose to prevent recurrent urinary tract infections in older women
This study tests whether a simple sugar called D-mannose can help prevent repeat urinary tract infections (UTIs) in postmenopausal women. If you have had frequent UTIs, this trial will see if D-mannose is a good option to keep you infection-free.
Dallas, TexasAges 55–85 - NCT06907199RecruitingPhase 1
Antibiotic vs. bladder treatment plus antibiotic for recurrent UTIs
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
Kansas City, KansasAges 18–85 - NCT06808451Recruiting
Comparing DNA test vs. standard culture for UTI diagnosis
This study compares two ways to diagnose urinary tract infections: a newer DNA test (PCR) versus the standard urine culture. The goal is to see if the DNA test finds infections faster and more accurately, so you can get the right treatment sooner.
Cleveland, OhioAges 18 years+ - NCT06724588Enrolling by invitation
Bacteria and drug resistance in people with repeat UTIs
This study looks at bacteria in urine samples from people who get frequent urinary tract infections and have a certain type of catheter. It aims to learn why some bacteria are hard to treat and may help improve care for patients like you.
LeuvenAges 18 years+ - NCT06702449RecruitingPhase 1/Phase 2
UTI vaccine safety and immune response study for adults 18-64
This trial tests a new vaccine to prevent urinary tract infections (UTIs). It first checks safety and immune response in healthy adults, then in women with recent E. coli UTIs. The goal is to see if the vaccine can reduce future infections.
Lenexa, KansasAges 18–64 - NCT06409819RecruitingPhase 1/Phase 2
Phage therapy for recurrent UTIs in kidney transplant patients
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
La Jolla, CaliforniaAges 18 years+ - NCT05913180RecruitingPhase 2
Vitamin C to prevent urine infections after gynecologic surgery
This Phase 2 study tests whether taking vitamin C can lower the chance of getting a urinary tract infection (UTI) after planned gynecologic surgery. It may help people who want to reduce post-surgery infection risk.
MoscowAges 18–80 - NCT05711446Recruiting
Studying repeat urine leaks and bladder infections after kidney transplant
This study looks at how often kidney transplant patients get bladder infections after transplant, especially around routine follow-up visits. It may help the clinic find ways to lower infection risk after transplant.
New York, New YorkAges 18 years+ - NCT05458700Recruiting
Study of complicated urinary tract infections
This study looks at complicated urinary tract infections (UTIs), which are infections in the urinary system that happen when there is an underlying issue like a urinary catheter, blockage, or other urinary tract problem. The trial aims to gather information to better understand and treat these infections.
Seville, SevillaAges 18 years+ - NCT04876131RecruitingPhase 4
Single-dose IV antibiotics for children with complicated urinary tract infections
This trial tests whether one dose of intravenous (IV) antibiotics is as effective as the usual multiple-dose course for children with complicated urinary tract infections (UTIs) who need IV treatment in the emergency department. It aims to reduce hospital stays and the need for repeated IV lines.
Adelaide, South AustraliaAges 3 months–18 years - NCT05488340RecruitingPhase 2
Study drug for hard-to-treat bladder infection in women
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
Fresno, CaliforniaAges 18–75 - NCT06004739Recruiting
Antibiotics for older adults with delirium and abnormal urine tests
This trial tests whether giving antibiotics helps older adults in the hospital who have delirium (sudden confusion) and signs of bacteria in their urine but no clear urinary infection. It aims to see if treatment can improve confusion and avoid unnecessary antibiotics.
Chicago, IllinoisAges 60 years+ - NCT06719232Recruiting
Testing a new way to give bladder treatment without a catheter
This study tests a catheter-free method for delivering medication directly into the bladder. It may help patients with bladder pain, recurrent infections, bladder cancer, or cystitis after radiation or chemotherapy.
BudapestAges 18–80 - NCT07308808RecruitingEarly Phase 1
Safety of a live bacteria solution for bladder infections
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07184827RecruitingPhase 3
U101 capsules to prevent recurring UTIs in women
This trial tests an oral capsule called U101 to see if it can prevent recurrent urinary tract infections (UTIs) in women who have frequent UTIs. If you've had at least 2 UTIs in the last 6 months or 3 in the last year, you may be able to join.
Chiayi CityAges 20–75 - NCT07186465RecruitingPhase 4
Preventing repeat bladder infections in postmenopausal women
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
Bangkok, Phayatai RatchathewiAges 40 years+ - NCT06953271RecruitingPhase 4
Methenamine after Botox for bladder control
This study tests whether taking a medication called methenamine hippurate (a pill for preventing UTIs) after Botox bladder injections can help reduce the risk of urinary tract infections. It may be a good option for women and non-binary people with overactive bladder who are already getting Botox treatment.
Providence, Rhode IslandAges 18 years+ - NCT06588010RecruitingPhase 3
Testing OM-89 to reduce antibiotic use for UTIs in neurogenic bladder
This trial tests whether a medication called OM-89 (a bacterial extract taken by mouth) can help reduce how often you need antibiotics for urinary tract infections (UTIs). It is for people with a neurogenic bladder from a spinal cord injury who use a catheter to empty their bladder and have had many UTIs in the past year.
DijonAges 18 years+
Hear when a new Urinary Tract Infections (UTIs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for urinary tract infections (utis)?
- Yes. Clin2 currently lists 58 recruiting urinary tract infections (utis) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a urinary tract infections (utis) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a urinary tract infections (utis) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.